JAMA study finds cancer drug data is still largely unavailable to qualified researchers
As data sharing has become more helpful and relevant to researchers in the past few years, a new report in JAMA Oncology shows that the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
